SCHEMBL23920175

SCHEMBL23920175

CCC(C)(C)CCCn1cccn1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.37
KDM4E B2RXH2 1/20 0.35
TLR8 Q9NR97 1/20 0.35
TLR7 Q9NYK1 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
FDPS P14324 1/20 0.33
THRB P10828 1/20 0.31
POLB P06746 2/20 0.31
MITF O75030 1/20 0.31
TSHR P16473 1/20 0.31
BRS3 P32247 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
OPRM1 P35372 1/20 0.31
OPRD1 P41143 1/20 0.31
LMNA P02545 2/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12374993 0.85 DAO (0.39) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL23919993 0.78 TLR8 (0.36) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL7100687 0.77 DAO (0.43) DAOTLR8TLR7L3MBTL1FDPS
SCHEMBL13715227 0.77 DAO (0.36) DAOKDM4ETLR8TLR7FDPS
SCHEMBL16815831 0.77 DAO (0.39) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL855608 0.76 DAO (0.38) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL23920419 0.76 TLR8 (0.37) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL796651 0.76
Bromide SCHEMBL556174 0.74 TLR8 (0.44) DAOKDM4ETLR8TLR7L3MBTL1
SCHEMBL45207 0.74 TLR8 (0.44) DAOTLR8TLR7L3MBTL1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 TRUSTEES OF BOSTON UNIVERSITY (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317114-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 IL4, IL2, IL4I1 DAO 2876/4885KDM4E 586/4885TLR8 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.